(19)

(11)

EP 2 023 895 A2

(12)

(88) Date of publication A3: 13.03.2008 (43) Date of publication: 18.02.2009 Bulletin 2009/08 (21) Application number: 07777015.4 (22) Date of filing: 11.05.2007

(51) International Patent Classification (IPC):  A61K 9/107(2006.01) A61K 38/14(2006.01) A61K 9/19(2006.01) (86) International application number: PCT/US2007/011465 (87) International publication number: WO 2007/133711 (22.11.2007 Gazette 2007/47)

(84) Designated Contracting States: AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR Designated Extension States: AL BA HR MK RS (30) Priority: 12.05.2006 US 800133 P (71) Applicant: Adventrx Pharmaceuticals, Inc. San Diego, CA 92121 (US)	(72) Inventor: CHEN, Andrew, Xian 92130 California (US) (74) Representative: Stuart, Ian Alexander et al Mewburn Ellis LLP 33 Gutter Lane London EC2V 8AS London EC2V 8AS (GB)